REVIEWS

Cytokines and oncogenes in cellular interactions of rheumatoid arthritis

GM Keyszer, AH Heer, and S Gay
Stem Cells 1994; 12: 75-86. [Abstract]

ORIGINAL ARTICLES

Protein-tyrosine kinases: potential targets for anticancer drug development

TR Burke Jr
Stem Cells 1994; 12: 1-6. [Abstract]

The design and synthesis of a new anticancer drug based on a natural product lead compound: from neplanocin A to cyclopentenyl cytosine (CPE- C)

JS Driscoll and VE Marquez
Stem Cells 1994; 12: 7-12. [Abstract]

Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDS

JN Weinstein, T Myers, J Buolamwini, K Raghavan, W van Osdol, J Licht, VN Viswanadhan, KW Kohn, LV Rubinstein, and AD Koutsoukos
Stem Cells 1994; 12: 13-22. [Abstract]

The use of animal models in cancer drug discovery and development

GA Curt
Stem Cells 1994; 12: 23-29. [Abstract]

Clinical development of anticancer agents from natural products

DR Parkinson, SG Arbuck, T Moore, JM Pluda, and MC Christian
Stem Cells 1994; 12: 30-43. [Abstract]

Anti-tumorigenic chalcones

S Shibata
Stem Cells 1994; 12: 44-52. [Abstract]

Highlight on the studies of anticancer drugs derived from plants in China

R Han
Stem Cells 1994; 12: 53-63. [Abstract]

Plant-derived drugs acting on cellular Ca2+ mobilization in vascular smooth muscle: tetramethylpyrazine and tetrandrine

CY Kwan
Stem Cells 1994; 12: 64-67. [Abstract]

Mass spectrometry in the development of drugs from traditional medicines

FW McLafferty and MW Senko
Stem Cells 1994; 12: 68-73. [Abstract]

Effects of gamma-irradiation on the M-CSF-promoter linked to a chloramphenicol aminoacyl transferase reporter gene expressed in a clonal murine bone marrow stromal cell line

MA Sakakeeny, M Harrington, J Leif, W Merrill, D Pratt, E Romanik, M McKenna, TJ FitzGerald, and JS Greenberger
Stem Cells 1994; 12: 87-94. [Abstract]

CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors

S Fruehauf, R Haas, WJ Zeller, and W Hunstein
Stem Cells 1994; 12: 95-102. [Abstract]

Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony- stimulating factor (rHuM-CSF)

CJ Kovacs, JP Harrell, MJ Evans, RS Abernathy, CJ Roberts, and RM Johnke
Stem Cells 1994; 12: 103-113. [Abstract]

Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panninga [published erratum appears in Stem Cells (Dayt) 1994 Mar;12(2):233]

TL Holyoake, MJ Alcorn, LJ Richmond, MG Freshney, C Pearson, E Fitzsimons, WP Steward, DJ Dunlop, and IB Pragnell
Stem Cells 1994; 12: 114-124. [Abstract]

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

AM Marmont
Stem Cells 1994; 12: 125-135.

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.